Login
Memorial Day
Premier League
Formula 1
Champions League
Social Media
French Open
Motorsports
Artificial Intelligence
Donald Trump
Israel-Hamas Conflict
Military
Manchester United
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Lallemand and Kirin announce distribution deal for IMMUSE postbiotic

Summary by nutraingredients.com
Lallemand Health Solutions and Kirin Holdings Company have announced a global strategic partnership to enhance the visibility and market reach of IMMUSE, a postbiotic for immune support.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
nutraingredients.comnutraingredients.com

Lallemand and Kirin announce distribution deal for IMMUSE postbiotic

Lallemand Health Solutions and Kirin Holdings Company have announced a global strategic partnership to enhance the visibility and market reach of IMMUSE, a postbiotic for immune support.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

nutraingredients.com broke the news in on Wednesday, May 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal